Rock Springs Capital Management LP Day One Biopharmaceuticals, Inc. Transaction History

Rock Springs Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$9.12 - $17.47 $3.48 Million - $6.67 Million	-381,939 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.65 - $26.33 $86,075 - $144,815	5,500 Added 1.46%	381,939 $6.44 Million
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.92 $54,000 - $75,384	2,700 Added 0.72%	376,439 $8.93 Million
Q2 2021 Aug 16, 2021	BUY	$19.0 - $23.69 $7.1 Million - $8.85 Million	373,739 New	373,739 $8.51 Million

179

84.2M

144K

218K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $899M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.